Cancer Home > Cladrabine

Were you looking for information about Cladribine? Cladrabine is a common misspelling of cladribine.
A healthcare provider may prescribe cladribine (Leustatin®) to treat a certain type of cancer called hairy cell leukemia. The medication is approved for use in adults only, and works by slowing down the growth of cancer cells.
Cladribine is injected slowly into a vein continuously for seven days. Your dosage will be determined based on your weight and how you respond to the drug.
(Click Cladribine to learn more about this drug, including dosing guidelines and a list of side effects that may occur with treatment. You can also click any of the links in the box to the right for specific information.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.